SLC2A1 and colorectal carcinoma: Through our analysis, we found that the expression levels of BGN (p = 0.01), SLC2A1 (p = 0.01), and STC2 (p = 0.03) significantly increased with the progression of CRC, while the expression level of NEDD4L (p = 0.04) decreased (Figure 3).